Results 81 to 90 of about 27,707 (119)

Wolfram syndrome and diabetes mellitus in Aotearoa, New Zealand: Phenotype and response to GLP-1 receptor agonist therapy. [PDF]

Diabet Med
L'Amie A, Vincent AL, Jefferies CA, Braatvedt G, Wiltshire E, Mouat F, Albert BB, Murphy R.   +7 more
europepmc   +1 more source

Comment on "Reduced Complications and Improved Survival With Postoperative GLP-1 Receptor Agonist Use Following Lumbar Arthrodesis". [PDF]

Global Spine J
Wang J.
europepmc   +1 more source

GLP-1 receptor agonist therapy and skeletal muscle: A narrative review synthesizing adult evidence with implications for older adults. [PDF]

JAR Life
Jagasia K, Pfeiffer AM, Vitale K.
europepmc   +1 more source

HbA1c kinetics as a prognostic marker of ophthalmic risk in GLP-1 receptor agonist therapy. [PDF]

Metabol Open
Margoni A, Papavassiliou KA, Papavassiliou AG.   +2 more
europepmc   +1 more source

Dietary Intake as an Undermeasured Potential Mediator: The Ethical Case for Complete and Transparent Dietary Reporting in GLP-1 Receptor Agonist Trials. [PDF]

Nutrients
Strosahl JN, Ziegler TR, Singh RH.
europepmc   +1 more source

Dynamics of Body Composition and Metabolic Risk in Adolescents With Obesity Under GLP-1 Receptor Agonist Therapy. [PDF]

Acta Paediatr
Lopez A, Perl L, Cohen-Sela E, Borger O, Issan Y, Interator H, Azoulay E, Moran-Lev H, Lubetzky R, Zelber-Sagi S, Lebenthal Y, Brener A.   +11 more
europepmc   +1 more source

Comparative Gynecological Safety of the Dual GIP/GLP-1 Receptor Agonist Tirzepatide vs. the GLP-1 Receptor Agonist Semaglutide: A Real-World Pharmacovigilance Analysis (2022-2025). [PDF]

Cureus
Makkena HB.
europepmc   +1 more source

Machine learning algorithms for predicting glycemic control and weight loss outcomes in GLP-1 receptor agonist users. [PDF]

Front Artif Intell
Abegaz TM, Frietze G.
europepmc   +1 more source

Altered eating experience during GLP-1 receptor agonist therapy: a sensory-liking-wanting framework for food preference and nutritional behaviour. [PDF]

Front Nutr
Du J, Yang Z, Chen Y.
europepmc   +1 more source